RXRX — RECURSION PHARMACEUTICALS IN

Ownership history in Engineers Gate Manager LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in RECURSION PHARMACEUTICALS IN (RXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2022 Q1)
Avg. % of fund
0.01%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,834 -83,673 -88.5% 0.00% $53K $4.88
2025 Q2 ADDED 94,507 +48,317 +104.6% 0.01% $478K $5.06
2024 Q4 REDUCED 46,190 -129,205 -73.7% 0.01% $312K $6.76
2024 Q3 ADDED 175,395 +97,604 +125.5% 0.02% $1.2M $6.59
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RXRX price (monthly, adj. close)

Other funds also holding RXRX

As of 2025 Q4 — sorted by position size

DCVC Opportunity Fund II GP, LLC 3Y 97.42% Data Collective IV GP, LLC 3Y 41.53% MIC Capital Management UK LLP 3Y 8.94% Nan Fung Group Holdings Ltd 3Y 2.18% ARK Investment Management LLC 3Y 7Y 1.01% Pivotal bioVenture Partners Investment Advisor LLC 3Y 0.94% Carroll Investors, Inc 3Y 0.79% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 0.68% Green Alpha Advisors, LLC 3Y 0.57% Lingotto Investment Management LLP 3Y 7Y 0.35%
← Back to Engineers Gate Manager LP Holdings